ORGANIZATION

• As 2025 Begins, Industry Leaders Renew Resolve towards Next Reforms
  January 6, 2025

• Japan Generic Use Rate at 84.7% in July-September: JGA
  December 27, 2024

• PhRMA/EFPIA Lash Out at Japan’s Plan for Mandatory Startup Fund
  December 26, 2024

• PhRMA/EFPIA Slam Govt for Off-Year Revision as Broader Industry Deplores Decision
  December 26, 2024

• Off-Year Revisions Need Careful Assessments and Discussions: Chuikyo JMA Rep
  December 20, 2024

• JPMA to Continue Seeking Repeal of Off-Year Revisions: Exec
  December 20, 2024

• JPA Calls for Improving Package Units as Pharmacies Suffer with Unsold Stocks of Pricey Meds
  December 19, 2024

• Japan Citizens’ Group Opposes RWD-Only Drug Submissions
  December 16, 2024

• EFPIA Japan Issues Joint Statement for Resolving Drug Lags/Losses
  December 12, 2024

• Pharma Labor Group Petitions MHLW to Scrap Off-Year Revisions
  December 3, 2024

• DPP Head, Industry Leaders United towards Stopping Off-Year Price Revisions
  November 29, 2024

• PhRMA Wants No Off-Year Price Cuts, Urges Japan Not to Backslide: Chair
  November 28, 2024

• JGA to Launch Study Group on Industry Revamp by End of FY2024
  November 26, 2024

• Japan Pharmacy Group Demands Abolishing Off-Year Price Revisions
  November 22, 2024

• Chuikyo Payer Rep Touts Necessity of FY2025 Off-Year Price Revision
  November 19, 2024

• Japan, US, Europe Trade Groups Urge Ishiba Govt to Scrap Off-Year Revisions
  November 18, 2024

• JPMA Appreciates Growing Calls for Abolition of Off-Year Revisions: Exec
  November 15, 2024

• Osaka’s New Life Science Hub to Grow into Full Ecosystem in 5 Years: Operator
  November 12, 2024

• Self-Medication and Proper Drug Pricing 2 Sides of the Same Coin: Professor
  November 8, 2024

• Japan Wholesaler Group to Continue Stressing Plight of Supply Disruption
  October 25, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• …
• Next ›
• 最終 »